9.1 Anticipating Pharmacologic Needs
Key Takeaways
- RCIS Task 12 requires anticipating medications from procedure type, access route, allergies, renal function, and institutional protocol before the operator requests them
- Diagnostic cath commonly uses 2,000–5,000 units IV heparin (or ~50 U/kg) with ACT targets around 200–250 seconds; PCI uses 70–100 U/kg with higher ACT goals
- Radial cases anticipate spasmolytic cocktails (verapamil ± nitroglycerin) and heparin to reduce radial artery occlusion even during diagnostic studies
- FFR cases require staged adenosine hyperemia with atropine and pacing support available; adenosine has an ultra-short half-life (~10 seconds)
- Review antiplatelet and anticoagulant history (P2Y12 loads, DOACs, HIT) before vascular access and stage emergency reversal/pressor drugs at the bedside
9.1 Anticipating Pharmacologic Needs
Quick Answer: RCIS Task 12 expects you to anticipate medications before the operator asks—based on procedure type, access route, hemodynamics, renal function, allergies, and institutional protocol. Pre-stage anticoagulation, antiplatelet support, vasodilators, antiarrhythmics, contrast prep, and resuscitation drugs so delays never compromise the patient or the case.
Pharmacology in the cath lab is not pharmacy trivia—it is procedural choreography. The invasive specialist who reads the schedule, reviews the chart, and lines up the right syringes before the patient enters the room prevents spasm during radial access, thrombus during long PCI, hypotension during sedation, and contrast nephropathy in renal impairment. CCI Domain B (diagnostic and interventional support) weights medication anticipation heavily because delays in anticoagulation, spasm treatment, or reversal agents directly affect outcomes.
RCIS Scope: Anticipate, Prepare, Communicate
Your role is support, not independent prescribing. You:
- Review the medication list, allergies (especially iodinated contrast, heparin, protamine, latex, chlorhexidine), and relevant labs (creatinine/eGFR, potassium, INR, platelet count, hemoglobin).
- Stage commonly used agents per protocol before vascular access.
- Calculate or verify weight-based doses when the operator orders them (heparin bolus, protamine, amiodarone load).
- Notify the operator of contraindications, recent P2Y12 loads, anticoagulant use, or renal dosing concerns.
- Document times, doses, routes, and responses per institutional policy.
When an item asks what you should do before the procedure starts, the best answer usually involves checking allergies and renal function and having emergency medications immediately available—not waiting until a complication occurs.
Procedure-Based Anticipation Matrix
| Clinical scenario | Medications commonly anticipated | RCIS preparation notes |
|---|---|---|
| Diagnostic coronary angiography | IV unfractionated heparin (UFH) (often 2,000–5,000 units or ~50 U/kg after access); radial spasm cocktail (verapamil/diltiazem ± nitroglycerin intra-arterially) | Lower ACT target (~200–250 sec) than PCI; still anticoagulate for radial to reduce radial artery occlusion (RAO) |
| PCI / ACS | UFH 70–100 U/kg (or bivalirudin per protocol); P2Y12 loading (ticagrelor/prasugrel/clopidogrel per plan); GP IIb/IIIa if ordered; intracoronary nitroglycerin for sizing/spasm | Target ACT 250–300 sec with GP IIb/IIIa; 300+ sec without; confirm aspirin given unless contraindicated |
| FFR/iFR assessment | Adenosine IV or IC hyperemia (FFR); atropine available for prolonged AV block/bradycardia with adenosine | Stage flushes, stopcock, and ECG monitoring before hyperemia; know half-life ~10 sec for adenosine |
| Structural / transseptal | UFH to ACT >250 sec (often 250–350) after LA access; reversal plan | Some centers heparinize only after successful puncture—know your lab protocol |
| Sedation cases | Midazolam/fentanyl (or propofol where credentialed); flumazenal/naloxone at bedside | Monitor SpO₂, EtCO₂ if available, blood pressure; anticipate hypotension and respiratory depression |
| Renal impairment / contrast risk | IV hydration per protocol; minimize contrast volume; hold metformin per policy | Anticipate N-acetylcysteine only if your institution uses it—follow written protocol |
| Contrast allergy / premedication | Prednisone + diphenhydramine (or institutional H1/H2 block + steroid regimen) when ordered | Confirm premed completed before contrast; still have epinephrine ready |
Weight-Based Doses You Must Pre-Calculate
| Agent | Typical cath lab dosing | When to calculate early |
|---|---|---|
| UFH bolus | 70–100 U/kg IV for PCI | Before large patients or pediatric-adjacent weights—verify with dual nurse check |
| Protamine | 1 mg per 100 units UFH given in last ~60 min (max ~50 mg); slower infusion if high dose | After prolonged cases or when ACT remains elevated at closure |
| Amiodarone | 150 mg IV over 10 min for VT/VF (then infusion per ACLS) | VT during PCI—have drawn before high-risk lesions |
| Atropine | 0.5–1 mg IV (repeat to 3 mg) for symptomatic bradycardia | Before adenosine, carotid sinus manipulation, or temporary pacing insertion |
| Epinephrine / norepinephrine / phenylephrine | Push-dose pressors per ACLS or institutional chart | Any unstable hemodynamics, anaphylaxis to contrast, or profound sedation effect |
Always use the patient's actual weight from the record—not guess from appearance—and confirm units (heparin is in units, not mg).
Access-Route and Spasm Anticipation
Radial access demands more proactive pharmacology than femoral in many labs:
- Intra-arterial spasmolytics (verapamil 2.5–5 mg, nitroglycerin 100–200 mcg) are often given prophylactically or at first resistance.
- UFH after wire/sheath placement reduces RAO even during diagnostic cases.
- Analgesia (local lidocaine, systemic fentanyl if sedated) reduces sympathetically driven spasm.
Femoral access still requires heparin for diagnostic and interventional cases, but spasm is less prominent—anticipate closure device needs and ACT before sheath pull (~150–180 sec or per protocol).
Antiplatelet and Anticoagulant History
Before the case, clarify:
| Finding | Anticipation action |
|---|---|
| Recent P2Y12 load (<24–72 h depending on agent) | Confirm with operator—may affect timing of surgery elsewhere or bleeding risk |
| DOAC (apixaban, rivaroxaban, etc.) | Operator decides hold vs continue; stage blood products if high bleeding risk |
| Warfarin with elevated INR | May delay elective case; have vitamin K/PCC plan only per physician order |
| HIT history | No heparin—anticipate bivalirudin or argatroban and notify pharmacy early |
| Thrombocytopenia | Confirm platelet threshold for procedure; stage platelet transfusion if ordered |
Contrast and Renal Protection
Iodinated contrast media are not "just fluids"—they are pharmacologically active osmolar loads. Anticipate:
- Hydration (normal saline often 1–1.5 mL/kg/h before and after per protocol).
- Contrast volume tracking—know cumulative mL and mL/kg especially in CKD, diabetes, heart failure, and repeat studies.
- Hold nephrotoxic drugs (metformin, NSAIDs) per policy after the procedure.
- Low-osmolar or iso-osmolar agents per formulary—still require allergy screening.
Emergency Trays and "Never Hunt" Drugs
Every occupied cath lab should have immediately reachable:
- Atropine, epinephrine, calcium chloride (if using)
- Amiodarone / lidocaine per ACLS
- Nitroglycerin (IV and IC syringes)
- Adenosine (if lab performs FFR or SVT termination)
- Flumazenil / naloxone when sedation used
- Dextrose / glucagon for hypoglycemia in diabetics
- Diphenhydramine / methylprednisolone / epinephrine for anaphylaxis
RCIS items often pair anticipation with sterile technique and Universal Protocol—the medication plan is part of the time-out when high-risk drugs (anticoagulation, thrombolytics, prolonged sedation) are expected.
Communication Checklist Before First Contrast Injection
- Allergies and premedication status confirmed with team
- Anticoagulation plan stated (agent, target ACT, reversal available)
- Spasm and sedation drugs drawn or verified on tray
- Weight documented for weight-based boluses
- Renal risk mitigation (hydration, volume limit) discussed
- Emergency pressors and antiarrhythmics within arm's reach
Anticipating pharmacologic needs is how an RCIS candidate proves intra-procedural readiness—the same readiness CCI tests when it asks what you prepare before adenosine, before PCI heparin, or before contrast in a patient with eGFR 28 mL/min/1.73 m².
A 62-year-old patient with eGFR 32 mL/min/1.73 m² is scheduled for diagnostic coronary angiography via radial access. Which preparation best reflects RCIS anticipation responsibilities before the case?
The operator plans PCI with planned GP IIb/IIIa inhibitor use. Which ACT target and heparin approach should you anticipate verifying?
A patient reports heparin-induced thrombocytopenia (HIT) in the medical record. What should you anticipate before an interventional case?